The Valley Desk

Healthcare research from Johnson & Johnson, page 3

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 49–72

Listings

  1. ArticleAdvances in therapy

    Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting Analysis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. ArticleDermatology and therapy

    The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, University of Pennsylvania. Affiliation source

    Disease researchAdded

  3. ArticleDermatology and therapy

    Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  4. ArticleDermatology and therapy

    Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  5. ReviewCNS drugs

    The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  6. ReviewDrug safety

    Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  7. ReviewPharmacoEconomics

    A Systematic Literature Review on the Economic Burden of Sjögren's Disease

    Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source

    Public healthAdded

  8. ArticlePharmaceutical medicine

    Best Practices for Medical Information Global Response Documents from phactMI and MILE

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  9. ArticleOncology and therapy

    Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  10. ArticleOncology and therapy

    Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. ArticleOncology and therapy

    IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel Treatment

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  12. ArticleOncology and therapy

    A Qualitative Study of Patient and Caregiver Perspectives on Locally Advanced Head and Neck Cancer in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  13. ReviewRheumatology and therapy

    Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  14. ReviewRheumatology and therapy

    Humanistic Burden of Sjögren's Disease: A Systematic Review of Treatment Efficacy on Health-Related Quality of Life

    Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source

    Clinical careAdded

  15. ArticleDrugs - real world outcomes

    Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  16. ArticleDrugs - real world outcomes

    Complications and Occurrence of Exacerbations in Patients with Myasthenia Gravis Treated with Oral Corticosteroids

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  17. ReviewPulmonary therapy

    Practical Considerations for Managing Transitions from Parenteral Prostacyclins to Oral Selexipag in Pulmonary Arterial Hypertension

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  18. ArticlePharmacoEconomics - open

    Valuing Maintenance of Visual Function in Retinitis Pigmentosa: A Discrete Choice Experiment with Patients and the General Public

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  19. ReviewAdvanced drug delivery reviews

    High-Dose Subcutaneous Administration of Biologics: Overcoming Barriers Through Formulation and Device Innovation

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  20. Clinical trial reportAnnals of the rheumatic diseases

    A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  21. ArticleAnnals of the rheumatic diseases

    Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

    Clinical careAdded

  22. ArticleAnnals of the rheumatic diseases

    PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  23. ArticleBiologicals : journal of the International Association of Biological Standardization

    Leveraging analytical and bioprocess platforms for biological product development and commercialization - A meeting report

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  24. ArticleBiological psychiatry global open science

    Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded